1148122-15-9

Basic information

• Product Name: 6-Chloro-2-phenyl-4-pyrimidinecarbonyl chloride
• Synonyms: 6-Chloro-2-phenyl-4-pyrimidinecarbonyl chloride
• CAS NO: 1148122-15-9
• Molecular Formula: C₁₁H₆Cl₂N₂O
• Molecular Weight: 253.08414
• Mol File: 1148122-15-9.mol
• Article Data: 5

Chemical Properties

• Appearance: /
• CAS DataBase Reference: 6-Chloro-2-phenyl-4-pyrimidinecarbonyl chloride(CAS DataBase Reference)
• NIST Chemistry Reference: 6-Chloro-2-phenyl-4-pyrimidinecarbonyl chloride(1148122-15-9)
• EPA Substance Registry System: 6-Chloro-2-phenyl-4-pyrimidinecarbonyl chloride(1148122-15-9)

Safety Data

• HazardClass: IRRITANT
• Hazardous Substances Data: 1148122-15-9(Hazardous Substances Data)

Usage

General Description

6-Chloro-2-phenyl-4-pyrimidinecarbonyl chloride is a chemical compound with the molecular formula C12H8ClN3O2. It is a carbonyl chloride derivative of pyrimidine, containing a chlorine atom on the 6th carbon, a phenyl group on the 2nd carbon, and a carbonyl chloride functional group. 6-Chloro-2-phenyl-4-pyrimidinecarbonyl chloride is a reagent commonly used in organic synthesis for the introduction of pyrimidine scaffolds in the preparation of various pharmaceuticals and agrochemicals. It is often employed in the synthesis of heterocyclic compounds and can undergo various chemical reactions, such as nucleophilic substitution and condensation reactions, to form a wide range of derivatives. 6-Chloro-2-phenyl-4-pyrimidinecarbonyl chloride is a valuable building block in the pharmaceutical industry and can be used in the production of antiviral, antibacterial, and anticancer drugs.

Upstream product

• 913952-59-7 6-chloro-2-phenylpyrimidine-4-carboxylic acid 
• 325685-59-4 4-chloro-6-methoxymethyl-2-phenylpyrimidine 
• 339278-89-6 6-methoxymethyl-2-phenylpyrimidin-4-ol 
• 618-39-3 benzamidin 
• 325685-75-4 4-Chloro-6-hydroxymethyl-2-phenylpyrimidine 
• 84659-98-3 6-hydroxy-2-phenylpyrimidine-4-carboxylic acid 

Downstream Products

• 1152093-84-9 6-chloro-2-phenyl-N-(2-(thiazolo[5,4-b]pyridin-2-yl)phenyl)pyrimidine-4-carboxamide 
• 1152095-44-7 6-chloro-2-phenyl-N-(2-(thiazolo[5,4-c]pyridin-2-yl)phenyl)pyrimidine-4-carboxamide 
• 1021703-38-7 4-{(S)-4-tert-butoxycarbonyl-2-[(6-chloro-2-phenyl-pyrimidine-4-carbonyl)-amino]-butyryl}-piperazine-1-carboxylic acid butyl ester 
• 913947-47-4 C₃₀H₃₄N₆O₆ 
• 913952-10-0 C₂₅H₃₂N₆O₇ 
• 913948-91-1 4-{(S)-4-tert-butoxycarbonyl-2-[(6-cyclopropyl-2-phenyl-pyrimidine-4-carbonyl)-amino]-butyryl}-piperazine-1-carboxylic acid ethyl ester 
• 913948-88-6 4-{(S)-4-tert-butoxycarbonyl-2-[(6-isopropyl-2-phenyl-pyrimidine-4-carbonyl)-amino]-butyryl}-piperazine-1-carboxylic acid ethyl ester 
• 913951-70-9 4-{(S)-4-tert-butoxycarbonyl-2-[(2-phenyl-6-pyridin-4-yl-pyrimidine-4-carbonyl)-amino]-butyryl}-piperazine-1-carboxylic acid ethyl ester 
• 913951-69-6 4-{(S)-4-tert-butoxycarbonyl-2-[(2-phenyl-6-pyridin-3-yl-pyrimidine-4-carbonyl)-amino]-butyryl}-piperazine-1-carboxylic acid ethyl ester 
• 913948-93-3 4-{(S)-4-tert-butoxycarbonyl-2-[(2,6-diphenyl-pyrimidine-4-carbonyl)-amino]-butyryl}-piperazine-1-carboxylic acid ethyl ester 
• 913952-11-1 C₂₆H₃₂N₆O₈ 
• 913950-00-2 4-((S)-4-tert-butoxycarbonyl-2-{[6-(3-hydroxy-prop-1-ynyl)-2-phenyl-pyrimidine-4-carbonyl]-amino}-butyryl)-piperazine-1-carboxylic acid ethyl ester 
• 913947-39-4 C₂₇H₃₇N₇O₆ 
• 913947-43-0 C₂₉H₃₉N₇O₇ 

Relevant articles and documents

HETEROBIARYL COMPOUNDS AND IMAGING AGENTS FOR IMAGING HUNTINGTIN PROTEIN

Provided herein are compounds of Formula I and imaging agents useful for detecting a disease or condition associated with protein aggregation, compositions thereof, and methods of their use.

SOLUBILIZED THIAZOLOPYRIDINES

Provided herein are novel sirtuin-modulating compounds Structural Formula (I): and methods of use thereof. The sirtuin-modulating compounds may be used for increasing the lifespan of a cell, and treating and/or preventing a wide variety of diseases and disorders including, for example, diseases or disorders related to aging or stress, diabetes, obesity, neurodegenerative diseases, cardiovascular disease, blood clotting disorders, inflammation, cancer, and/or flushing as well as diseases or disorders that would benfit from increased mitochondrial activity. Also provided are compositions comprising a sirtuin-modulating compound in combination with another therapeutic agent.

Piperazinyl-glutamate-pyrimidines as potent P2Y12 antagonists for inhibition of platelet aggregation

Piperazinyl-glutamate-pyrimidines were prepared with oxygen, nitrogen, and sulfur substitution at the 4-position of the pyrimidine leading to highly potent P2Y12 antagonists. In particular, 4-substituted piperidine-4-pyrimidines provided compou